S11.3 Low-dose interleukin-2 therapy in active systemic lupus erythematosus (lupil-2): a multi-center, double-blind, randomized and placebo-controlled phase 2 trial di J Smolen, G Riemekasten, P Cacoub, J Humrich, D Leroux, G Tsokos, M Rosenzwajg, D Klatzmann, H Pham, T Vázquez, F Pitoiset, J Guidoux